ACUTA CAPITAL PARTNERS, LLC Hedge Fund

CIK: 0001582844 · Show all filings

Period: Q1 2020 (← Previous) (Next →)

Filing Date: May 15, 2020

Total Value ($000): $206,318 (100.0% shares, 0.0% debt)

Holdings (32)

AVADEL PHARMACEUTICALS PLC 10.2%
Value ($000) $20,949 Shares 2,673,718 Est. Cost $7.66 Unrealized
AXSM AXSOME THERAPEUTICS INC 8.8%
Value ($000) $18,149 Shares 308,500 Est. Cost $23.68 Unrealized +244.1%
ADVERUM BIOTECHNOLOGIES INC 8.1%
Value ($000) $16,653 Shares 1,704,500 Est. Cost $11.13 Unrealized
IOVA IOVANCE BIOTHERAPEUTICS INC 5.8%
Value ($000) $11,959 Shares 399,500 Est. Cost $7.92 Unrealized +234.8%
ARVN ARVINAS INC 5.5%
Value ($000) $11,289 Shares 280,120 Est. Cost $19.30 Unrealized +142.4%
AUPH AURINIA PHARMACEUTICALS INC 5.4%
Value ($000) $11,173 Shares 770,000 Est. Cost $6.93 Unrealized +154.5%
BELLUS HEALTH INC NEW 5.2%
Value ($000) $10,679 Shares 1,070,000 Est. Cost $7.29 Unrealized
KADMON HLDGS INC 4.8%
Value ($000) $9,888 Shares 2,360,000 Est. Cost $3.68 Unrealized
VERASTEM INC 4.6%
Value ($000) $9,496 Shares 3,720,930 Est. Cost $2.55 Unrealized
XENE XENON PHARMACEUTICALS INC 3.5%
Value ($000) $7,127 Shares 628,500 Est. Cost $8.16 Unrealized +74.6%
ASND ASCENDIS PHARMA A S 3.4%
Value ($000) $7,117 Shares 63,200 Est. Cost $122.05 Unrealized
BIOXCEL THERAPEUTICS INC 3.4%
Value ($000) $7,040 Shares 315,000 Est. Cost $22.35 Unrealized
CATALYST BIOSCIENCES INC 2.9%
Value ($000) $6,051 Shares 1,384,600 Est. Cost $4.37 Unrealized
SELECTA BIOSCIENCES INC 2.8%
Value ($000) $5,698 Shares 2,364,204 Est. Cost $2.26 Unrealized
APLS APELLIS PHARMACEUTICALS INC 2.7%
Value ($000) $5,613 Shares 209,500 Est. Cost $28.50 Unrealized +24.6%
LIFESCI ACQUISITION CORP 2.7%
Value ($000) $5,599 Shares 560,000 Est. Cost $10.00 Unrealized
MERSANA THERAPEUTICS INC 2.3%
Value ($000) $4,824 Shares 827,500 Est. Cost $5.83 Unrealized
DICERNA PHARMACEUTICALS INC 2.3%
Value ($000) $4,712 Shares 256,500 Est. Cost $22.03 Unrealized
CONSTELLATION PHARMCETICLS I 2.1%
Value ($000) $4,383 Shares 139,464 Est. Cost $47.11 Unrealized
KARUNA THERAPEUTICS INC 2.0%
Value ($000) $4,032 Shares 56,000 Est. Cost $75.34 Unrealized
REATA PHARMACEUTICALS INC 1.6%
Value ($000) $3,392 Shares 23,500 Est. Cost $80.29 Unrealized
APPLIED THERAPEUTICS INC 1.6%
Value ($000) $3,334 Shares 102,000 Est. Cost $18.14 Unrealized
ARWR ARROWHEAD PHARMACEUTICALS IN 1.5%
Value ($000) $3,156 Shares 109,700 Est. Cost $23.72 Unrealized +70.1%
RLMD RELMADA THERAPEUTICS INC 1.5%
Value ($000) $3,102 Shares 90,950 Est. Cost $40.32 Unrealized 0.0%
QURE UNIQURE NV 1.2%
Value ($000) $2,515 Shares 53,000 Est. Cost $56.25 Unrealized +2.1%
MARINUS PHARMACEUTICALS INC 1.0%
Value ($000) $2,107 Shares 1,038,000 Est. Cost $2.03 Unrealized
GLOBAL BLOOD THERAPEUTICS IN 1.0%
Value ($000) $1,993 Shares 39,000 Est. Cost $51.10 Unrealized
KURA KURA ONCOLOGY INC 1.0%
Value ($000) $1,970 Shares 198,000 Est. Cost $16.00 Unrealized -28.5%
ZAFGEN INC 0.5%
Value ($000) $1,067 Shares 1,386,000 Est. Cost $1.02 Unrealized
BCRX BIOCRYST PHARMACEUTICALS 0.2%
Value ($000) $500 Shares 250,000 Est. Cost $2.52 Unrealized +9.5%
IVERIC BIO INC 0.2%
Value ($000) $478 Shares 139,000 Est. Cost $8.58 Unrealized
ABUS ARBUTUS BIOPHARMA CORP 0.1%
Value ($000) $273 Shares 269,907 Est. Cost $2.70 Unrealized 0.0%